DBV Technologies | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Acadia Pharmaceuticals USD 762M 80.42M 2025-06
Alnylam Pharmaceuticals USD 1.11B 94.03M 2025-06
Amarin USD 119.52M 1.51M 2025-03
BioMarin Pharmaceutical USD 1.21B 601.78M 2025-06
DBV Technologies USD 0 0 2025-03
Halozyme Therapeutics USD 61.86M 114.47M 2025-06
Incyte USD 2.42B 13.08M 2025-06
Insmed USD 1.28B 881.08M 2025-06
Ionis Pharmaceuticals USD 297.3M 33.11M 2025-06
Neurocrine Biosciences USD 264M 69.9M 2025-06
PTC Therapeutics USD 1.02B 1.01B 2025-06
Sarepta Therapeutics USD 510.6M 269.73M 2025-06
Ultragenyx Pharmaceutical USD 166.11M 396.9M 2025-06
United Therapeutics USD 1.59B 306.8M 2025-06


DBV Technologies Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.